| US 7,570,997 B2 | ||
| Subcutaneous cardiac rhythm management with asystole prevention therapy | ||
| Eric G. Lovett, Roseville, Minn. (US); Adam W. Cates, Minneapolis, Minn. (US); Darrell Orvin Wagner, Isanti, Minn. (US); Mike Favet, San Jose, Calif. (US); and Apurv Kamath, Solana Beach, Calif. (US) | ||
| Assigned to Cardiac Pacemakers, Inc., St. Paul, Minn. (US) | ||
| Filed on Apr. 08, 2004, as Appl. No. 10/820,642. | ||
| Claims priority of provisional application 60/462272, filed on Apr. 11, 2003. | ||
| Prior Publication US 2004/0215258 A1, Oct. 28, 2004 | ||
| Int. Cl. A61N 1/362 (2006.01) | ||
| U.S. Cl. 607—14 [67/4; 67/10; 67/63] | 61 Claims |

| 1. A system, comprising:
detection circuitry;
energy delivery circuitry capable of delivering a plurality of cardiac therapies comprising at least a tachycardia therapy,
a bradycardia therapy, and an asystole prevention therapy;
therapy instructions stored in the energy delivery circuitry, the therapy instructions executable to direct delivery of the
plurality of cardiac therapies;
one or more electrodes configured for subcutaneous, non-intrathoracic placement in a patient and for coupling to the detection
circuitry and energy delivery circuitry;
detection circuitry configured to receive cardiac signals using the one or more electrodes and detect a tachycardia condition,
a bradycardia condition, and an asystole condition using the cardiac signals;
a controller coupled to the detection circuitry and energy delivery circuitry, the controller, in response to a cardiac condition
requiring treatment, executing at least some of the therapy instructions to coordinate delivery of a selected one of the tachycardia,
bradycardia, and asystole prevention therapies, the asystole prevention therapy being delivered at a rate below that of the
bradycardia therapy and at 20 pulses per minute or less upon detection of the asystole condition;
a patient-external communications device configured to receive data relating to the selected one of the tachycardia, bradycardia,
and asystole prevention therapies, wherein the patient-external communications device facilitates communication with a network
or server system; and
a display coupled to the patient-external communications device for displaying the received data.
|